Literature DB >> 22193671

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.

Kelly Posner1, Gregory K Brown, Barbara Stanley, David A Brent, Kseniya V Yershova, Maria A Oquendo, Glenn W Currier, Glenn A Melvin, Laurence Greenhill, Sa Shen, J John Mann.   

Abstract

OBJECTIVE: Research on suicide prevention and interventions requires a standard method for assessing both suicidal ideation and behavior to identify those at risk and to track treatment response. The Columbia-Suicide Severity Rating Scale (C-SSRS) was designed to quantify the severity of suicidal ideation and behavior. The authors examined the psychometric properties of the scale.
METHOD: The C-SSRS's validity relative to other measures of suicidal ideation and behavior and the internal consistency of its intensity of ideation subscale were analyzed in three multisite studies: a treatment study of adolescent suicide attempters (N=124); a medication efficacy trial with depressed adolescents (N=312); and a study of adults presenting to an emergency department for psychiatric reasons (N=237).
RESULTS: The C-SSRS demonstrated good convergent and divergent validity with other multi-informant suicidal ideation and behavior scales and had high sensitivity and specificity for suicidal behavior classifications compared with another behavior scale and an independent suicide evaluation board. Both the ideation and behavior subscales were sensitive to change over time. The intensity of ideation subscale demonstrated moderate to strong internal consistency. In the adolescent suicide attempters study, worst-point lifetime suicidal ideation on the C-SSRS predicted suicide attempts during the study, whereas the Scale for Suicide Ideation did not. Participants with the two highest levels of ideation severity (intent or intent with plan) at baseline had higher odds for attempting suicide during the study.
CONCLUSIONS: These findings suggest that the C-SSRS is suitable for assessment of suicidal ideation and behavior in clinical and research settings.

Entities:  

Mesh:

Year:  2011        PMID: 22193671      PMCID: PMC3893686          DOI: 10.1176/appi.ajp.2011.10111704

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey.

Authors:  R C Kessler; G Borges; E E Walters
Journal:  Arch Gen Psychiatry       Date:  1999-07

Review 2.  Neurobiology of suicidal behaviour.

Authors:  J John Mann
Journal:  Nat Rev Neurosci       Date:  2003-10       Impact factor: 34.870

3.  Worst-point suicidal plans: a dimension of suicidality predictive of past suicide attempts and eventual death by suicide.

Authors:  Thomas E Joiner; Robert A Steer; Gregory Brown; Aaron T Beck; Jeremy W Pettit; M David Rudd
Journal:  Behav Res Ther       Date:  2003-12

4.  Prevalence of and risk factors for suicide attempts versus suicide gestures: analysis of the National Comorbidity Survey.

Authors:  Matthew K Nock; Ronald C Kessler
Journal:  J Abnorm Psychol       Date:  2006-08

Review 5.  A current perspective of suicide and attempted suicide.

Authors:  J John Mann
Journal:  Ann Intern Med       Date:  2002-02-19       Impact factor: 25.391

6.  Eventual suicide in interrupted and uninterrupted attempters: a challenge to the cry-for-help hypothesis.

Authors:  R A Steer; A T Beck; B Garrison; D Lester
Journal:  Suicide Life Threat Behav       Date:  1988

7.  Assessment of suicidal intention: the Scale for Suicide Ideation.

Authors:  A T Beck; M Kovacs; A Weissman
Journal:  J Consult Clin Psychol       Date:  1979-04

Review 8.  Assessment of suicide risk.

Authors:  K Hawton
Journal:  Br J Psychiatry       Date:  1987-02       Impact factor: 9.319

9.  Incidence of suicide ideation and attempts in adults: the 13-year follow-up of a community sample in Baltimore, Maryland.

Authors:  W H Kuo; J J Gallo; A Y Tien
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

10.  Risk factors for suicide in psychiatric outpatients: a 20-year prospective study.

Authors:  G K Brown; A T Beck; R A Steer; J R Grisham
Journal:  J Consult Clin Psychol       Date:  2000-06
View more
  986 in total

Review 1.  Suicide risk in youth with intellectual disabilities: the challenges of screening.

Authors:  Erica Ludi; Elizabeth D Ballard; Rachel Greenbaum; Maryland Pao; Jeffrey Bridge; William Reynolds; Lisa Horowitz
Journal:  J Dev Behav Pediatr       Date:  2012-06       Impact factor: 2.225

2.  Non-Suicidal Self-Injury in Pediatric Bipolar Disorder: Clinical Correlates and Impact on Psychosocial Treatment Outcomes.

Authors:  Heather A MacPherson; Sally M Weinstein; Amy E West
Journal:  J Abnorm Child Psychol       Date:  2018-05

3.  Ecological assessment of daily suicidal thoughts and attempts among suicidal teens after psychiatric hospitalization: Lessons about feasibility and acceptability.

Authors:  E K Czyz; C A King; I Nahum-Shani
Journal:  Psychiatry Res       Date:  2018-06-21       Impact factor: 3.222

4.  Using structured telephone follow-up assessments to improve suicide-related adverse event detection.

Authors:  Sarah A Arias; Zi Zhang; Carla Hillerns; Ashley F Sullivan; Edwin D Boudreaux; Ivan Miller; Carlos A Camargo
Journal:  Suicide Life Threat Behav       Date:  2014-03-03

5.  Change in suicidal ideation after interdisciplinary treatment of chronic pain.

Authors:  John Kowal; Keith G Wilson; Peter R Henderson; Lachlan A McWilliams
Journal:  Clin J Pain       Date:  2014-06       Impact factor: 3.442

Review 6.  Suicide and suicidal behaviour.

Authors:  Gustavo Turecki; David A Brent
Journal:  Lancet       Date:  2015-09-15       Impact factor: 79.321

7.  Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.

Authors:  Stephen K Brannan; Sharon Sawchak; Andrew C Miller; Jeffrey A Lieberman; Steven M Paul; Alan Breier
Journal:  N Engl J Med       Date:  2021-02-25       Impact factor: 91.245

8.  A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.

Authors:  Graham J Emslie; Apurva Prakash; Qi Zhang; Beth A Pangallo; Mark E Bangs; John S March
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

Review 9.  Evidence for the management of adolescent depression.

Authors:  R Eric Lewandowski; Mary C Acri; Kimberly E Hoagwood; Mark Olfson; Greg Clarke; William Gardner; Sarah Hudson Scholle; Sepheen Byron; Kelly Kelleher; Harold A Pincus; Samantha Frank; Sarah M Horwitz
Journal:  Pediatrics       Date:  2013-09-16       Impact factor: 7.124

10.  Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.

Authors:  Robert L Findling; Adelaide Robb; Anjana Bose
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.